AstraZeneca PLC
AZN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $203 | $210 | $210 | $165 |
| - Cash | $5 | $6 | $6 | $6 |
| + Debt | $30 | $29 | $29 | $31 |
| Enterprise Value | $228 | $233 | $233 | $190 |
| Revenue | $54 | $46 | $44 | $37 |
| % Growth | 18% | 3.3% | 18.5% | – |
| Gross Profit | $44 | $38 | $32 | $25 |
| % Margin | 81.1% | 82% | 72.1% | 66.8% |
| EBITDA | $15 | $13 | $9 | $5 |
| % Margin | 28.6% | 29.3% | 20.5% | 13.7% |
| Net Income | $7 | $6 | $3 | $0 |
| % Margin | 13% | 13% | 7.4% | 0.3% |
| EPS Diluted | 1.13 | 1.91 | 1.06 | 0.04 |
| % Growth | -40.8% | 80.2% | 2,550% | – |
| Operating Cash Flow | $12 | $10 | $10 | $6 |
| Capital Expenditures | -$5 | -$4 | -$3 | -$2 |
| Free Cash Flow | $7 | $7 | $7 | $4 |